| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |